Proliferative activity, angiogenesis and nuclear morphometry in renal cell carcinoma

被引:22
作者
Kirkali, Z [1 ]
Yorukoglu, K
Ozkara, E
Kazimoglu, H
Mungan, U
机构
[1] Dokuz Eylul Univ, Sch Med, Dept Urol, TR-35340 Izmir, Turkey
[2] Dokuz Eylul Univ, Sch Med, Dept Pathol, TR-35340 Izmir, Turkey
关键词
angiogenesis; Ki-67; kidney; morphometry; renal cell carcinoma;
D O I
10.1046/j.1442-2042.2001.00405.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Prognostic parameters other than tumor stage and grade are essential for renal cell carcinoma (RCC) patients. This study was undertaken to determine the usefulness of cellular proliferation, angiogenesis and nuclear morphometry in predicting the biological aggressiveness of RCC. Methods: Surgical specimens of 70 patients with RCC were investigated by conventional histology, Ki-67 immunostaining and stereological assessment of angiogenesis and mean nuclear volume. Results: There was no difference in disease-specific survival with respect to sex, age and histopathological type (except sarcomatoid and other types). The survival was significantly lower and the chance of metastases was higher in the group with higher proliferative activity (P = 0.007). There was no relation between angiogenesis, mean nuclear volume, stage and survival. There was a significant relation between both Fuhrman and WHO grades, tumor stage and survival. Histopathological type, grade, angiogenesis and mean nuclear volume failed to predict recurrences and/or metastases. In multivariate analysis, only TNM stage and proliferative activity were found to be independent prognostic factors. Conclusions: In addition to tumor grade and stage, proliferative activity of a given RCC may have the potential to identify patients with an impaired prognosis.
引用
收藏
页码:697 / 703
页数:7
相关论文
共 25 条
[1]  
Delahunt B, 1998, SEMIN DIAGN PATHOL, V15, P68
[2]   PROGNOSTIC-SIGNIFICANCE OF MORPHOLOGIC PARAMETERS IN RENAL-CELL CARCINOMA [J].
FUHRMAN, SA ;
LASKY, LC ;
LIMAS, C .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1982, 6 (07) :655-663
[3]  
Gelb AB, 1997, CANCER-AM CANCER SOC, V80, P1768, DOI 10.1002/(SICI)1097-0142(19971101)80:9<1768::AID-CNCR11>3.0.CO
[4]  
2-3
[5]  
Giberti C, 1997, EUR UROL, V31, P40
[6]   THE NEW STEREOLOGICAL TOOLS - DISECTOR, FRACTIONATOR, NUCLEATOR AND POINT SAMPLED INTERCEPTS AND THEIR USE IN PATHOLOGICAL RESEARCH AND DIAGNOSIS [J].
GUNDERSEN, HJG ;
BAGGER, P ;
BENDTSEN, TF ;
EVANS, SM ;
KORBO, L ;
MARCUSSEN, N ;
MOLLER, A ;
NIELSEN, K ;
NYENGAARD, JR ;
PAKKENBERG, B ;
SORENSEN, FB ;
VESTERBY, A ;
WEST, MJ .
APMIS, 1988, 96 (10) :857-881
[7]  
HERMANEK P, 1997, UICC TNM ATLAS ILLUS
[8]  
HOFMOCKEL G, 1995, CANCER, V76, P296, DOI 10.1002/1097-0142(19950715)76:2<296::AID-CNCR2820760221>3.0.CO
[9]  
2-L
[10]  
Jochum W, 1996, CANCER, V77, P514